Patents by Inventor Éva Schmidt

Éva Schmidt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9994525
    Abstract: The present invention relates to new histamine H3 (H3) receptor subtype selective ligands of the general formula (I) and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and the use of these compounds as medicaments for treatment and/or prevention of conditions which require modulation of H3 receptors. The invention also cover the combinations of a compound of the general formula (I) and an acetylcholinesterase inhibitor.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: June 12, 2018
    Assignee: Richter Gedeon Nyrt.
    Inventors: Gizella Bartáné Szalai, Gäbor András Wágner, Béla Kiss, Éva Schmidt, Ottília Balázs, Noémi Nagy
  • Publication number: 20160009645
    Abstract: The present invention relates to new histamine H3 (H3) receptor subtype selective ligands of the general formula (I) and/or geometric isomers and/or stereoisomers and/or diastereomers and/or salts and/or hydrates and/or solvates thereof. The invention further relates to pharmaceutical compositions containing such compounds and the use of these compounds as medicaments for treatment and/or prevention of conditions which require modulation of H3 receptors. The invention also cover the combinations of a compound of the general formula (I) and an acetylcholinesterase inhibitor.
    Type: Application
    Filed: March 6, 2014
    Publication date: January 14, 2016
    Inventors: Gizella BARTÁNÉ SZALAI, Gábor András WÁGNER, Béla KISS, Éva SCHMIDT, Ottília BALÁZS, Noémi NAGY
  • Patent number: 7183283
    Abstract: The invention relates to new piperidinyl-alkylamino-pyridazinone derivatives of the general Formula (I) (wherein R is hydrogen or C1-4-alkyl; one of X and Y stands for hydrogen and the other represents a group of the general Formula (II) Hal stands for halogen; and n is 1 or 2) and pharmaceutically acceptable acid addition salts thereof a process for the preparation thereof and pharmaceutical compositions comprising said compounds.
    Type: Grant
    Filed: December 28, 2002
    Date of Patent: February 27, 2007
    Assignee: Egis Gyogyszergyar RT.
    Inventors: József Barkóczy, István Gacsályi, László Gábor Hársing, Péter Kótay Nagy, György Lévay, Éva Schmidt, Gyula Simig
  • Patent number: 7098210
    Abstract: The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel compounds possess neuroleptic effect and can be used, primarily, for the treatment of schizophrenia. In formula I, R stands for a hydrogen atom or a C1-4, alkyl group, X and Y represent, independently, a hydrogen atom, a halogen atom or a group of the formula II, with the proviso that one of X and Y means always a group of the formula II, and then the other one stands for a hydrogen atom or a halogen atom, wherein in formula II n has a value of 1 or 2.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: August 29, 2006
    Assignee: Egis Gyógyszergyár Rt.
    Inventors: József Barkóczy, Péter Kótay Nagy, Gyula Simig, György Lévay, István Gacsályi, András Egyed, Judit Ráczné Bajnógel, Katalin Pallagi, Éva Schmidt, Gábor Szénási, Anikó Miklósné Kovács, János Wellmann
  • Patent number: 6930110
    Abstract: The invention relates to substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R1 is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R2 is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R3 stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C1-4 alkyl); Z stands for oxygen; or R3 and Z together with the groups placed between them form a piperazine ring; and R4 stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: August 16, 2005
    Assignee: Egis Gyogyszergyar Rt.
    Inventors: József Barkóczy, András Egyed, István Gacsályi, László Hársing, Hajnalka Kompagne, Péter Kótay Nagy, György Lévay, Csilla Leveleki, Bernadett Martonné Markó, Anikó Miklósné Kovács, Éva Schmidt, Gyula Simig, Gábor Szénási, János Wellmann
  • Patent number: 6191152
    Abstract: The invention refers to novel 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives of formula (I) having an influence on the heart and the central nervous system, furthermore pharmaceutical compositions containing the above derivatives, and a process for the preparations of the novel compounds.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: February 20, 2001
    Assignee: EGIS Gyógyszergyar Rt.
    Inventors: József Reiter, József Barkóczy, Gábor Berecz, Gyula Simig, András Egyed, Katalin Ivanicsné Megyeri, Sándor Drabant, Szabolcs Kertész, Anikó Miklósné Kovács, Ildikó Nagyné Gyönös, Mária Szécseyné Hegedüs, Gábor Szénási, János Wellmann, Katalin Pallagi, Éva Schmidt, Károly Tihanyi, Péter Trinka, Margit Csörgö